Korean Celltrion Makes First Big Global Move with Acquisition of…
Korean biosimilar firm Celltrion’s USD 266 million acquisition of Japanese outfit Takeda assets in the Asia-Pacific region marks a significant…
Tagged with Takeda
Top 10 Pharma Companies in Japan
Japan’s pharma market is one of the world’s biggest, with a value of around USD 95 billion, according to figures from the country’s…
What Can a Plasma ‘Alliance’ do for COVID-19?
A newly formed ‘Plasma Alliance’ of the world’s leading blood plasma companies believed that plasma from those who have recovered from COVID-19…
Speeding up the Search for Safe & Effective COVID-19…
IFPMA Director General Thomas B. Cueni shares the outcomes of a recent high level pharma industry media briefing on the search for a COVID-19…
The UAE: A Gathering Force
Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat overlooked by many drug makers, most…
Words of Wisdom for New Pharma Country Managers in Romania
Despite the challenging characteristics of the Romanian market, with a large population of nearly 20 million people and significant unmet medical…
Sweden: An Innovation Nation
Sweden’s USD 4.8 billion pharmaceutical market, its population size of 10 million and marginal positioning on the northerly fringe of the European…
5 Questions to 5 Leading Pharma Execs on the COVID-19 Pandemic
The CEOs and top executives, David Ricks, chairman and CEO, Eli Lilly & Co and IFPMA president, Severin Schwan, CEO, Roche, Paul Stoffels, chief…
A New Era of Access to Innovation in the Czech Republic?
Pharma industry stakeholders are generally quick to suggest that the Czech Republic is one of the most over-regulated markets in Europe, with new or…
Orphan Drugs: Building the Regulatory Framework in the Czech…
A cross-industry push for better and broader access to innovative treatments is underway in the Czech Republic. Ripe for reform is the country’s…
Dominika Kovacs – Country Manager, Takeda Romania
Dominika Kovacs, country manager of Takeda Romania, shares her insights on the growing pipeline of the organisation and the anticipated launch of a…
Mahender Nayak – Head, India, CIS, Middle East, Turkey…
With nearly 240 years of history behind it, Takeda continues to position itself as a leading global R&D-driven biopharmaceutical organization. Dr…
